BDBM620852 (3S,4S) or (3R,4R) 4-(4-(2-((1- (2,2-(R) or (S) difluorocyclopropyl)-5-methyl- 1H-pyrazol-4-yl)amino)-6- methylquinazolin-7-yl)piperazin- 1-yl)tetrahydrofuran-3-ol::US20230303540, Example Ex-5.2

SMILES Cc1c(Nc2ncc3cc(C)c(cc3n2)N2CCN(CC2)C2COCC2O)cnn1C1CC1(F)F

InChI Key InChIKey=CMKSADPNJRVOOX-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 620852   

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM620852((3S,4S) or (3R,4R) 4-(4-(2-((1- (2,2-(R) or (S) di...)
Affinity DataIC50: 0.450nMAssay Description:The LRRK2 kinase activity reported herein as IC50 values was determined with LanthaScreen technology from Life Technologies Corporation (Carlsbad, CA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
US Patent